We fund and coach healt company willing to put on the market new treatment


We focus exclusively on financing rigorously selected healthcare products that are close to market launch. These are typically diagnostic tests, medical devices or e-solutions.

We bring significant value by working closely with each team on the clinical study design, the market access strategy and all communication aspects.

Our success is closely linked to the commercial success of each product because we will receive a percentage of the overall annual royalties paid to investors. Thus, we have a vested interest in selecting quality projects and products....
We fund and coach healt company willing to put on the market new treatment


We focus exclusively on financing rigorously selected healthcare products that are close to market launch. These are typically diagnostic tests, medical devices or e-solutions.

We bring significant value by working closely with each team on the clinical study design, the market access strategy and all communication aspects.

Our success is closely linked to the commercial success of each product because we will receive a percentage of the overall annual royalties paid to investors. Thus, we have a vested interest in selecting quality projects and products.
More information

Recommendations

Bruno Schneider - Le Saout

Bruno Schneider - Le Saout European Equity Crowdfunding Regulatory Affairs and ecosystem development advisor at Strategist

MPC has a great pan-European alternative finance business model to facilitate MedTech / Biotech SMEs to get over the "death valley". MPC proposition is meeting an existing demand of companies, with a proof of concept in order to get their product and its market developed further.